Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Melanoma

Free Subscription Articles published in J Immunother Retrieve available abstracts of 24 articles: HTML format

Single Articles

April 2008
1. VON EULER H , Sadeghi A, Carlsson B, Rivera P, et al
   Efficient Adenovector CD40 Ligand Immunotherapy of Canine Malignant Melanoma.
   J Immunother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. KOIKE N , Pilon-Thomas S, Mule JJ
   Nonmyeloablative Chemotherapy Followed by T-cell Adoptive Transfer and Dendritic Cell-based Vaccination Results in Rejection of Established Melanoma.
   J Immunother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
3. RUTTINGER D , Li R, Poehlein CH, Haley D, et al
   Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein.
   J Immunother. 2008;31:43-51.
   PubMed     Related articles    Abstract available
   
   
   April 2007
4. FRIEBE A , Schwarz MJ, Schmid-Wendtner M, Volkenandt M, et al
   Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.
   J Immunother. 2007;30:333-7.
   PubMed     Related articles    Abstract available
   
   
   February 2007
5. APPAY V , Voelter V, Rufer N, Reynard S, et al
   Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma.
   J Immunother. 2007;30:240-50.
   PubMed     Related articles    Abstract available
   
   
   
6. BINS A , Mallo H, Sein J, van den Bogaard C, et al
   Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients.
   J Immunother. 2007;30:234-9.
   PubMed     Related articles    Abstract available
   
   
   January 2007
7. SMITH FO , Goff SL, Klapper JA, Levy C, et al
   Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody.
   J Immunother. 2007;30:130.
   PubMed     Related articles   
   
   
   
8. ZHAO Y , Sun Y, Niu Z, Li Q, et al
   A novel approach to generate host antitumor T cells: adoptive immunotherapy by T cells maturing in xenogeneic thymus.
   J Immunother. 2007;30:83-8.
   PubMed     Related articles    Abstract available
   
   
   
9. WESA A , Kalinski P, Kirkwood JM, Tatsumi T, et al
   Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient TH1-type antimelanoma CD4+ T cell responses in vitro.
   J Immunother. 2007;30:75-82.
   PubMed     Related articles    Abstract available
   
   
   
10. AGGER R , Petersen MS, Petersen CC, Hansen SB, et al
    T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging.
    J Immunother. 2007;30:29-39.
    PubMed     Related articles    Abstract available
    
    
    September 2006
11. PALUCKA AK , Ueno H, Connolly J, Kerneis-Norvell F, et al
    Dendritic Cells Loaded With Killed Allogeneic Melanoma Cells can Induce Objective Clinical Responses and MART-1 Specific CD8+ T-cell Immunity.
    J Immunother. 2006;29:545-557.
    PubMed     Related articles    Abstract available
    
    
    
12. DAVIS ID , Chen Q, Morris L, Quirk J, et al
    Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
    J Immunother. 2006;29:499-511.
    PubMed     Related articles    Abstract available
    
    
    July 2006
13. MAKER AV , Yang JC, Sherry RM, Topalian SL, et al
    Intrapatient Dose Escalation of Anti-CTLA-4 Antibody in Patients With Metastatic Melanoma.
    J Immunother. 2006;29:455-463.
    PubMed     Related articles    Abstract available
    
    
    
14. BARRIO MM , de Motta PT, Kaplan J, von Euw EM, et al
    A Phase I Study of an Allogeneic Cell Vaccine (VACCIMEL) With GM-CSF in Melanoma Patients.
    J Immunother. 2006;29:444-454.
    PubMed     Related articles    Abstract available
    
    
    
15. PILON-THOMAS S , Li W, Briggs JJ, Djeu J, et al
    Immunostimulatory Effects of CpG-ODN Upon Dendritic Cell-Based Immunotherapy in a Murine Melanoma Model.
    J Immunother. 2006;29:381-7.
    PubMed     Related articles    Abstract available
    
    
    
16. ZHAO Y , Zheng Z, Khong HT, Rosenberg SA, et al
    Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes.
    J Immunother. 2006;29:398-406.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    May 2006
17. JEROME V , Graser A, Muller R, Kontermann RE, et al
    Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
    J Immunother. 2006;29:294-305.
    PubMed     Related articles    Abstract available
    
    
    
18. SHAFER-WEAVER K , Rosenberg S, Strobl S, Gregory Alvord W, et al
    Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials.
    J Immunother. 2006;29:328-35.
    PubMed     Related articles    Abstract available
    
    
    
19. KIM TS , Chopra A, O-Sullivan IS, Cohen EP, et al
    Enhanced immunity to breast cancer in mice immunized with fibroblasts transfected with a complementary DNA expression library from breast cancer cells: Enrichment of the vaccine for immunotherapeutic cells.
    J Immunother. 2006;29:261-73.
    PubMed     Related articles    Abstract available
    
    
    
20. PETERSEN CC , Petersen MS, Agger R, Hokland ME, et al
    Accumulation in tumor tissue of adoptively transferred T cells: A comparison between intravenous and intraperitoneal injection.
    J Immunother. 2006;29:241-9.
    PubMed     Related articles    Abstract available
    
    
    March 2006
21. ROSENBERG SA , Sherry RM, Morton KE, Yang JC, et al
    Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines.
    J Immunother. 2006;29:224-31.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
22. LETSCH A , Keilholz U, Kern F, Asemissen AM, et al
    Specific central memory T cells in the bone marrow of patients immunized against tyrosinase peptides.
    J Immunother. 2006;29:201-7.
    PubMed     Related articles    Abstract available
    
    
    November 2005
23. WEISS JM , Allen C, Shivakumar R, Feller S, et al
    Efficient responses in a murine renal tumor model by electroloading dendritic cells with whole-tumor lysate.
    J Immunother. 2005;28:542-50.
    PubMed     Related articles    Abstract available
    
    
    
24. HINRICHS CS , Palmer DC, Rosenberg SA, Restifo NP, et al
    Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
    J Immunother. 2005;28:517-24.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: